Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A 12-week, Randomized, Multicenter, Double-blind, Active-controlled, Non-inferiority Study to Compare the Efficacy and Safety of Pitavastatin and Atorvastatin in High Risk Hypercholesterolemic Patients

NCT01386853 is registered in ClinicalTrials.gov with Tai Tien Pharmaceuticals Co., Ltd. as lead sponsor.

NCT NCT01386853
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01386853 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A 12-week, Randomized, Multicenter, Double-blind, Active-controlled, Non-inferiority Study to Compare the Efficacy and Safety of Pitavastatin and Atorvastatin in High Risk Hypercholesterolemic Patients
Lead sponsor
Tai Tien Pharmaceuticals Co., Ltd.
Phase
Phase 3
Overall status
Unknown status
Start date
July 31, 2011
Completion date
July 31, 2012
Enrollment
200 (estimated)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

hyperlipidemia